Company / Current Liabilities per Share
NEUROONE MEDICAL TECHNOLOGIES Corp Current Liabilities per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.07
FY2025
5-year range
$0.07 / $0.32
FY2021-FY2025
Trend
-19.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has declined for 4 consecutive years, from $0.32 in FY2021 to $0.07 in FY2025.
Based on SEC 10-K filings.
0.07 in FY2025 with a 10-year CAGR of +16.4%.
Improved from $0.11 to $0.07 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -33.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- +16.4%
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's current liabilities per share has declined for 4 consecutive years.
- In FY2025, current liabilities per share decreased 19.2% year-over-year.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.07 | -19.2% |
| FY2024 | $0.09 | -16.3% |
| FY2023 | $0.11 | -57.2% |
| FY2022 | $0.26 | -19.0% |
| FY2021 | $0.32 | +1270.7% |
| FY2016 | $0.02 | +41.5% |
| FY2015 | $0.02 | +134.1% |
| FY2014 | $0.01 | +93.9% |
| FY2012 | $0.00 | +251.8% |
| FY2011 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026